Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer
about
Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancerAndrogen Receptor: A Complex Therapeutic Target for Breast CancerEnhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling PathwaysSomatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence dataAre current drug development programmes realising the full potential of new agents? The scenario.Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnoverMinireview: Tipping the balance: ligand-independent activation of steroid receptors.PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.An integrated bioinformatics approach identifies elevated cyclin E2 expression and E2F activity as distinct features of tamoxifen resistant breast tumors.Biological subtypes of breast cancer: Prognostic and therapeutic implications.Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines.Deconstructing the molecular portraits of breast cancer.Luminal-B breast cancer and novel therapeutic targets.Hormonally responsive breast cancer cells in a microfluidic co-culture model as a sensor of microenvironmental activity.ERα-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization.Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review).Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.High-risk estrogen-receptor-positive breast cancer: identification and implications for therapy.Bayesian Inference on Malignant Breast Cancer in Nigeria: A Diagnosis of MCMC ConvergenceAntihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance.
P2860
Q27001260-5241B76F-9BE8-4F0B-94C6-53532283C416Q28075188-6BA47E50-FA91-4BCF-B38C-E49C0E5B30DCQ28084585-CAA9185E-F9B3-4C80-99BB-CA5ADD8BAF09Q30823432-D46B2459-1E4E-47DC-B3D3-45247607E1C6Q33555569-5989955E-A477-4829-84F6-BFB72C7026FFQ33611408-977497D0-AC39-481D-89CD-DF79F00D6B06Q33631775-9ABA7635-797D-4CDD-8D30-422B88A66E25Q33933172-9386A782-2B87-4A4D-9539-A833DD014F12Q33971409-0DFCDB24-0332-4717-BE87-0EBD9E9C602AQ34023695-BDB83993-6225-4D54-9739-28E1AD39D5B5Q34048134-DA77C76E-F6C6-4814-B095-C006C0B9DD97Q34066386-08DAB180-3866-4758-BF07-F6B7AE36AF5BQ34154147-5D3209E5-DEE3-4419-B622-BCA6405197FBQ35889534-CB3BF35C-E625-45E6-877C-4CBD7A8E717EQ36827824-883F98F3-2DBE-43EC-A568-3AD53A553888Q37302065-65FE5079-9F07-4C7C-9E43-F0BBB607F346Q37565213-911B9744-E12D-4F11-8B0D-B685D61A4A60Q37678826-406836A5-4275-425D-84D8-559639B49BFFQ38027578-EFDFD8E5-D26B-4536-82D4-21474464B9CEQ47233472-8924BA9C-CCB4-4745-9C68-31CB528B5B08Q54610139-242AD60C-460C-49FE-8BD1-9855348CD60E
P2860
Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gene expression profiling iden ...... eceptor positive breast cancer
@ast
Gene expression profiling iden ...... eceptor positive breast cancer
@en
Gene expression profiling iden ...... eceptor positive breast cancer
@nl
type
label
Gene expression profiling iden ...... eceptor positive breast cancer
@ast
Gene expression profiling iden ...... eceptor positive breast cancer
@en
Gene expression profiling iden ...... eceptor positive breast cancer
@nl
prefLabel
Gene expression profiling iden ...... eceptor positive breast cancer
@ast
Gene expression profiling iden ...... eceptor positive breast cancer
@en
Gene expression profiling iden ...... eceptor positive breast cancer
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Gene expression profiling iden ...... eceptor positive breast cancer
@en
P2093
Christos Sotiriou
Francoise Lallemand
Martine J Piccart
Nelly M Conus
P2860
P2888
P3181
P356
10.1186/1755-8794-2-37
P407
P577
2009-01-01T00:00:00Z
P5875
P6179
1014028949